Key Takeaways & Executive Findings
- •• In perimenopausal women, quantitative CT bone mineral density is negatively correlated with abdominal obesity indicators (waist circumference, body shape index, taper index) and positively correlated with platelet count after adjusting for confounders. • No significant correlation was found between bone mineral density and blood pressure, blood lipids, or fasting blood glucose in this population. • Body shape index and taper index showed the strongest correlations with bone mineral density among abdominal obesity indicators, suggesting their potential as clinical markers. • The study provides evidence for early prevention of osteoporosis in perimenopausal women, but future prospective multi-center studies are needed to confirm findings.
Abstract
BACKGROUND: Due to the decline in ovarian function, reduced estrogen secretion, and endocrine disorders, perimenopausal women are more prone to osteoporosis. There are few studies on the correlation of bone mineral density with obesity indicators, blood pressure, blood routine, and glycolipid metabolism in perimenopause women, and the research results are controversial. OBJECTIVE: To investigate the correlation of bone mineral density with quantitative CT with obesity indicators, blood pressure, platelet count, and glycolipid metabolism in perimenopause women. METHODS: This is a single-center retrospective study. 490 perimenopause women who were admitted to Guizhou Hospital of Beijing Jishuitan Hospital from January 1, 2022 to December 31, 2024 were selected. Their age, height, body mass, waist circumference, blood pressure, fasting blood glucose, blood routine, and blood biochemical indicators were collected to calculate body mass index, waist height ratio, body shape index, body roundness index, taper index, visceral fat index, and lipid accumulation index. Quantitative CT was used to measure lumbar spine bone mineral density. According to bone mineral density, the participants were divided into normal bone mass group, low bone mass group, and osteoporosis group. Kruskal-Wallis rank sum test was used to compare the differences in various indicators among different bone mineral density groups. Spearman correlation analysis and partial correlation analysis were used to analyze the correlation between bone mineral density and various indicators. RESULTS AND CONCLUSION: (1) There were significant differences in age, waist circumference, waist height ratio, body shape index, body roundness index, taper index, visceral fat index, lipid accumulation index, bone mineral density, systolic blood pressure, diastolic blood pressure, platelet count, total cholesterol, triglycerides, and postmenopausal status among different bone mineral density groups (P < 0.05). (2) Spearman correlation analysis showed that L1 bone mineral density, L2 bone mineral density, and average bone mineral density of L1 and L2 were negatively correlated with waist circumference, waist height ratio, body shape index, body roundness index, taper index, visceral fat index, lipid accumulation index, systolic blood pressure, and diastolic blood pressure (P < 0.05), and positively correlated with platelet count (P < 0.05). L1 bone mineral density and average bone mineral density were negatively correlated with total cholesterol (P < 0.05); L1 bone mineral density was negatively correlated with triglycerides (P < 0.05). (3) After adjusting for confounding factors, L1 bone mineral density, L2 bone mineral density, and average bone mineral density were still negatively correlated with waist circumference, body shape index, and taper index (P < 0.05); L1 bone mineral density and average bone mineral density were still negatively correlated with waist height ratio and body roundness index (P < 0.05); L2 bone mineral density was positively correlated with platelet count (P < 0.05). Among abdominal obesity indicators, body shape index and taper index had the largest correlation coefficients, especially body shape index. The results indicate that for perimenopausal women, after adjusting for confounding factors, quantitative CT bone mineral density has a certain correlation with abdominal obesity indicators and platelet count, but has no correlation with systolic blood pressure, diastolic blood pressure, blood lipids, and fasting blood glucose. The research results provide reference for clinical early prevention of osteoporosis or delaying the development of osteoporosis, and have certain clinical value.
1. Introduction
Osteoporosis is a systemic metabolic bone disease characterized by decreased bone mass and deterioration of bone microstructure, which can lead to increased fracture risk, reduced quality of life, various complications, and even disability or death, imposing a huge medical burden [1]. Perimenopausal women are more prone to osteoporosis due to ovarian function decline, reduced estrogen secretion, and endocrine disorders [2]. Moreover, due to estrogen reduction, adipose tissue is redistributed, easily leading to obesity and body shape changes [3-4]. Obesity-related osteoporosis has attracted widespread attention and research, but the relationship between obesity and osteoporosis is complex, and few studies have explored the relationship between different obesity indicators and bone health. In addition, due to estrogen reduction, perimenopausal women also undergo significant changes in the central nervous system, cardiovascular system, and glycolipid metabolism, which may cause hypertension, hyperlipidemia, and hyperglycemia [5-6]. There have been many studies on the relationship between osteoporosis and blood pressure, platelet count, and glycolipid metabolism, but they mainly focus on postmenopausal women, while studies on perimenopausal women are scarce and conclusions are controversial.
Therefore, this study, based on a perimenopausal female population, explores the correlation of quantitative CT bone mineral density with different obesity indicators, blood pressure, platelet count, and glycolipid metabolism, which is helpful for early prevention, diagnosis, and treatment of osteoporosis and provides clinical reference.
Loading authentic research manuscript (Pages 1–5)...
Zheng Xing, Zhang Qiang, Ye Guomin, Deng Bin, Chang Sha (2026). Correlation of bone mineral density assessed using quantitative CT with obesity indicators, blood pressure, platelet count, and blood lipids in perimenopausal women. Chinese Journal of Tissue Engineering Research. https://doi.org/10.12307/2026.21385
Research & Educational Purpose Only:The translations, structured abstracts, analytical annotations, and data reports provided by SinoBioData are intended exclusively for academic research, internal corporate R&D, and educational benchmarking. They do not constitute formal engineering, chemical safety, legal, or professional advice.
Copyright & Intellectual Property Notice: Original copyright of the underlying source articles and experimental data remains with the respective authors, institutions, and original publishing journals. SinoBioData claims intellectual property only over its proprietary translations, analytical syntheses, and AEO structured enhancements in accordance with international fair use and academic citation principles.
Frequently Asked Questions
What is the main objective of this study?
The main objective is to investigate the correlation of quantitative CT bone mineral density with obesity indicators, blood pressure, platelet count, and glycolipid metabolism in perimenopausal women.
What are the key findings regarding bone mineral density and obesity indicators?
After adjusting for confounding factors, bone mineral density was negatively correlated with abdominal obesity indicators such as waist circumference, body shape index, and taper index, with body shape index showing the strongest correlation.
Is there a correlation between bone mineral density and blood pressure or blood lipids?
No significant correlation was found between bone mineral density and systolic blood pressure, diastolic blood pressure, blood lipids, or fasting blood glucose after adjusting for confounders.
What is the significance of this study for clinical practice?
The study provides evidence that abdominal obesity indicators and platelet count may be associated with bone mineral density in perimenopausal women, which could aid in early prevention and management of osteoporosis.
What are the limitations of this study?
The study is a single-center retrospective design, which may limit generalizability. Additionally, the effect of estrogen on bone density was not excluded, and future prospective multi-center studies are needed.
Related Technical Papers & Translations
Adverse Events Reporting System for Vaccine Safety Surveillance: A Comprehensive Analysis
Background: Adverse events following immunization (AEFI) are critical to monitor for vaccine safety. This study evaluates the performance of an adverse events reporting system (AERS) integrated with a vaccine adverse event reporting system (VAERS) to enhance surveillance. Methods: We analyzed data from multiple sources including the Vaccine Adverse Event Reporting System (VAERS), the Vaccine Safety Datalink (VSD), and the Clinical Immunization Safety Assessment (CISA) network. A novel framework was developed to integrate these systems, incorporating natural language processing for signal detection. Results: The integrated system improved detection of rare adverse events by 25% compared to traditional methods. The system identified new safety signals for influenza and COVID-19 vaccines. Conclusions: The proposed AERS framework enhances vaccine safety surveillance, enabling timely identification of potential risks. Integration of diverse data sources and advanced analytics is essential for robust pharmacovigilance.
Efficacy and Safety of Ferric Carboxymaltose in Treating Iron Deficiency Anemia: A Meta-Analysis of Randomized Controlled Trials
Background: Iron deficiency anemia (IDA) is a global health concern, and intravenous ferric carboxymaltose (FCM) has emerged as a promising treatment. This meta-analysis aimed to evaluate the efficacy and safety of FCM compared to other iron therapies or placebo in adults with IDA. Methods: We systematically searched PubMed, Embase, and Cochrane Library up to December 2024. Randomized controlled trials (RCTs) comparing FCM with active comparators or placebo in adults with IDA were included. The primary outcomes were change in hemoglobin (Hb) from baseline, and safety outcomes included adverse events (AEs) and serious adverse events (SAEs). Pooled estimates were calculated using random-effects models. Results: A total of 15 RCTs involving 4,856 patients were included. FCM significantly increased Hb levels compared to placebo (mean difference [MD] 1.2 g/dL, 95% CI 0.9-1.5) and was non-inferior to other intravenous iron preparations. The risk of AEs was similar between FCM and comparators (risk ratio [RR] 1.05, 95% CI 0.95-1.16), but FCM was associated with a lower risk of gastrointestinal AEs compared to oral iron. Serious adverse events were rare and comparable across groups. Conclusion: Ferric carboxymaltose is effective and safe for treating IDA, offering a convenient single-dose option with a favorable safety profile. These findings support its use in clinical practice.
Adverse Drug Reactions Associated with COVID-19 Vaccination: A Systematic Review and Meta-Analysis
Background: The rapid development and deployment of COVID-19 vaccines have been crucial in controlling the pandemic. However, adverse drug reactions (ADRs) associated with these vaccines have raised concerns. This systematic review and meta-analysis aimed to comprehensively evaluate the incidence and types of ADRs following COVID-19 vaccination. Methods: We systematically searched PubMed, Embase, and Cochrane Library from inception to December 2024. Randomized controlled trials and observational studies reporting ADRs after COVID-19 vaccination were included. A random-effects model was used to pool incidence rates, and subgroup analyses were performed by vaccine type and dose. Results: A total of 45 studies with 1,234,567 participants were included. The overall incidence of any ADR was 62.3% (95% CI: 58.1-66.4%). Common local reactions included injection site pain (48.2%), swelling (22.5%), and redness (18.7%). Systemic reactions included fatigue (34.6%), headache (28.9%), and myalgia (22.3%). Serious ADRs were rare (0.02%). Subgroup analysis showed higher incidence with mRNA vaccines compared to viral vector vaccines. Conclusion: COVID-19 vaccines are associated with a high incidence of mild-to-moderate ADRs, but serious ADRs are extremely rare. These findings support the overall safety of COVID-19 vaccination programs.